Bayer
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Bayer sits in the top decile of US sponsors by registered trial count (#58 of 15,742 sponsors by registered trial count).
Bayer: 591 sponsored US clinical trials, 21 recruiting.
Bayer sponsors 591 registered US clinical trials on ClinicalTrials.gov, 21 of them currently recruiting, and 494 completed. 172 of these trials are in Phase 3-4 (later-stage) and 237 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Sunscreening Agents, with 17 trials.
Top-decile sponsor footprint
Bayer ranks in the top decile of sponsors by registered trial count (#58 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
494 of 552 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
591 total, page 5 of 12
Sun Protection Factor Assay (SPF Assay 204/2016)
NCT02936544
Sun Protection Factor Assay (SPF Assay 205/2016)
NCT02936557
Sun Protection Factor Assay (SPF Assay 206/2016)
NCT02936570
Sun Protection Factor Assay (SPF Assay 207/2016)
NCT02936583
Sun Protection Factor Assay (SPF Assay 203/2016)
NCT02930798
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
NCT02959827
Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
NCT02830477
Sun Protection Factor Assay (SPF Assay 199/2016)
NCT02930746
Sun Protection Factor Assay (SPF Assay 200/2016)
NCT02930759
Sun Protection Factor Assay (SPF Assay 201/2016)
NCT02930772
Sun Protection Factor Assay (SPF Assay 202/2016)
NCT02930785
Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole
NCT02824042
Supervised Outdoor-Use Test For Sunscreen Products in Adults
NCT02877511
Sun Protection Factor Assay (SPF Assay 104/2016)
NCT02891057
Sun Protection Factor Assay (SPF Assay 105/2016)
NCT02891044
Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms
NCT02865538
Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old
NCT02831478
Sun Protection Factor Assay
NCT02815241
Sun Protection Factor Assay (SPF Assay 19008)
NCT02815202
Sun Protection Factor Assay (SPF Assay 19009)
NCT02815228
Sun Protection Factor Assay
NCT02822339
Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating
NCT02842268
Phase I Trial of BAY1251152 for Advanced Blood Cancers
NCT02745743
Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer
NCT02751918
Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors
NCT02746081
Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US
NCT02788409
Human Photoallergy Test
NCT02750449
18850 - Human Photoallergy Test
NCT02751463
18793 - Human Photoallergy Test
NCT02750488
Exploratory Study for Allergy Relief Onset
NCT02722083
Human Phototoxicity Test
NCT02754102
18794 - Human Photo Toxicity Test
NCT02751372
Human Phototoxicity Test
NCT02750475
Human Phototoxicity Test
NCT02751541
Human Photoallergy Test
NCT02751515
Human Phototoxicity Test
NCT02751489
18842 - Sun Protection Factor Assay
NCT02717325
18841- Sun Protection Factor Assay
NCT02717351
18751-Sun Protection Factor Assay.
NCT02739802
18750-Sun Protection Factor Assay
NCT02741466
Evaluation of the Irritation Potential of Products in Human Eyes.
NCT02728856
Evaluation of the Irritation Potential of Products in Human Eyes
NCT02714166
Interaction With HIV Antiretroviral Agents
NCT02556268
18790 - Sun Protection Factor Assay
NCT02695303
18791 - Sun Protection Factor Assay
NCT02682628
Real-world Dosing Patterns of Rivaroxaban in the United States
NCT03242278
Real-world Comparative Effectiveness of Rivaroxaban Versus VKA
NCT02690155
Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist
NCT02687867
Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist
NCT02687854
A Multi-Site Evaluation of the Pain Relief, Support, Fit and Comfort From Use of a Custom Knee or Ankle Brace in Persons Suffering From Chronic Ankle or Knee Pain and Instability
NCT02682654
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 130 |
| Phase 2 | 107 |
| Phase 3 | 144 |
| Phase 4 | 28 |
What is open in the Bayer pipeline
21 recruiting of 591 indexed (4% open); 494 completed (84%).
Phase mix: 172 late (III/IV) vs 237 early (I/II) (balanced across stages).
Top condition: Sunscreening Agents (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Bayer: open-pipeline peers nationwide
Peers matched on 591 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
Bayer sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 591 trials (± recruiting share)
- Janssen Research & Development · 593 trials · 11% recruiting
- City of Hope Medical Center · 582 trials · 29% recruiting
- Children's Hospital Medical Center, Cincinnati · 571 trials · 19% recruiting
- National Institute of Neurological Disorders and Stroke (NINDS) · 567 trials · 8% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Bausch Health Americas · 4% recruiting · 168 trials
- Harvard Pilgrim Health Care · 4% recruiting · 28 trials
- Sumitomo Pharma America · 4% recruiting · 168 trials
- Teva Branded Pharmaceutical Products R&D · 4% recruiting · 167 trials
Related
What to do with this Bayer page
591 registered trials is a research-attention snapshot, not an endorsement of Bayer or any single study.
- 21 of Bayer's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Sunscreening Agents is the condition Bayer studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sunscreening Agents trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Bayer pipeline card: 591 registered trials from official public datasets.Report a data error.